Announcing first solid tumor indication in HPV associated-malignancies – NEXI-003 Advancing two lead product candidates in Phase 1/2 clinical trials Additional clinical and preclinical data …
Cyteir Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
– IPO raised an aggregate of approximately $149.1 million in gross proceeds – Strong cash position of $198.6 million to be used to deliver expected …
Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update
Total Revenue of $13.0 Million in 2Q 2021; TAZVERIK® Net Product Revenues of $8.0 Million Revised Commercial Strategy and Operating Plan to Accelerate Adoption of …
Pharvaris Reports Second Quarter 2021 Financial Results and Provides Business Highlights
RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks expanding to US, expected to report data in 2022 CHAPTER-1, Phase 2 …
Retail Opportunity Investments Corp. Reports Second Quarter 2021 Results
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three and six months …
Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights
Phase 3 randomized withdrawal trial for cardiomyopathy in Barth planned ReCLAIM Phase 1 data presented at ARVO 2021 supports ReCLAIM-2 Phase 2 geographic atrophy trial …
SinglePoint Reports First Quarter 2021 Financial Results and Provides Business Update
– Continued execution on strategy to build the most comprehensive national solar network and portfolio of renewable energy solutions to meet rapidly growing demand – …
Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
Strategic Partnerships Expand Drug Development Capabilities to More Efficiently and Rapidly Lead the Next Generation of Psychedelic-Assisted Therapeutics DENVER, May 18, 2021 (GLOBE NEWSWIRE) — …
Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights
Recently Announced Phase 3 INVIGORATE Clinical Trial Results Indicated Statistically Significant Activity of Reproxalap in Ocular Itching and Redness Associated with Allergic Conjunctivitis Top-Line Results …
Dun & Bradstreet Reports First Quarter 2021 Financial Results
Dun & Bradstreet Holdings, Inc. (NYSE: DNB), a leading global provider of business decisioning data and analytics, today announced unaudited financial results for the first …
Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations
BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate …
Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
– NDA for maralixibat in Alagille syndrome (ALGS) granted priority review by U.S. FDA; PDUFA date is September 29, 2021– Received additional $65.0 million in …
AnalytixInsight Reports 2020 Financial Results and Provides Business Update
TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Artificial Intelligence company, AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY; OTCQB: ATIXF), reports its financial results for …
Lufax Reports First Quarter 2021 Unaudited Financial Results | Business & Finance
SHANGHAI–(BUSINESS WIRE)–Apr 26, 2021– Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU), a leading technology-empowered personal financial services platform in China, today announced its …
Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update
MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its …
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
MINNEAPOLIS, March 26, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), is re-issuing this press release solely to correct an inadvertent decimal error in …
OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer, OSE-127/S95011 in ulcerative colitis, FR104 in renal transplant and an …
Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones
Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programs Ends 2020 with cash exceeding $33 million and a clean capital structure …
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that …
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing during Q2 2021 Cash and …